Last updated on November 2018

Safety Tolerability and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis


Brief description of study

The purpose of this open-label, pilot, proof of concept study is to evaluate the safety, tolerability, and efficacy of oral etrasimod (APD334) in patients with primary biliary cholangitis (PBC).

Clinical Study Identifier: NCT03155932

Contact Investigators or Research Sites near you

Start Over

Simone Strasser, Prof

Royal Prince Alfred Hospital
Camperdown, Australia
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.